Springbok Capital Management »

Taysha Gene Therapies shares owned by Springbok Capital Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Springbok Capital Management from 13F filings

Historical chart of Springbok Capital Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Springbok Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Springbok Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $670k 98k 6.81
2024-06-30 $418k 187k 2.24
2024-03-31 $160k 56k 2.87
2023-09-30 $759k 240k 3.16